David Yoo - Bellevue Life Chief Officer
| BLAC Stock | 11.17 0.09 0.80% |
Executive
David Yoo is Chief Officer of Bellevue Life Sciences
| Age | 50 |
| Address | 10900 NE 4th Street, Bellevue, WA, United States, 98004 |
| Phone | 425 635 7700 |
| Web | https://www.bellevuespac.com |
Bellevue Life Management Efficiency
The company has return on total asset (ROA) of (0.0298) % which means that it has lost $0.0298 on every $100 spent on assets. This is way below average. Bellevue Life's management efficiency ratios could be used to measure how well Bellevue Life manages its routine affairs as well as how well it operates its assets and liabilities. At present, Bellevue Life's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.01, whereas Return On Capital Employed is forecasted to decline to (0.06). At present, Bellevue Life's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 38.4 M, whereas Net Tangible Assets are projected to grow to (1.8 K).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Carlotta JD | Diamond Hill Investment | N/A | |
| Stuart Lewis | Deutsche Bank AG | 59 | |
| Norbert Winkeljohann | Deutsche Bank AG | 63 | |
| Jeffrey CPA | Diamond Hill Investment | 43 | |
| Julie JD | Visa Class A | 55 | |
| James Arculus | Deutsche Bank AG | N/A | |
| Sachin CPA | Brookfield Corp | 47 | |
| Suzanne Fleming | Brookfield Corp | N/A | |
| Christopher Suh | Visa Class A | 54 | |
| Gerd Schuetz | Deutsche Bank AG | 52 | |
| Yiwen Ma | Distoken Acquisition | 39 | |
| Shai Zelering | Brookfield Corp | N/A | |
| Bruce Larson | Carlyle Group | 60 | |
| Eduardo Salgado | Brookfield Corp | N/A | |
| Zhanming Zhang | Distoken Acquisition | 32 | |
| Henriette Mark | Deutsche Bank AG | 64 | |
| Alexander Muhlen | Deutsche Bank AG | 49 | |
| Kapil CFA | Carlyle Group | 39 | |
| Amit Jain | Carlyle Group | N/A | |
| Karen Sprogis | Blackstone Group | 63 | |
| Aleks Novakovic | Brookfield Corp | N/A | |
Management Performance
| Return On Asset | -0.0298 |
Bellevue Life Sciences Leadership Team
Elected by the shareholders, the Bellevue Life's board of directors comprises two types of representatives: Bellevue Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bellevue. The board's role is to monitor Bellevue Life's management team and ensure that shareholders' interests are well served. Bellevue Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bellevue Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bellevue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bellevue Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bellevue Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.